Company record
Apothecary Pharma, LLC
1 FDA warning letter since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Apothecary Pharma, LLC.
Warning letters
-
DrugsApothecary Pharma, LLC
FDA warns Apothecary Pharma, an outsourcing facility, that its sterile compounded drugs were made under insanitary conditions.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 14 | Class II | Apothecary Pharma LLC Drug |
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18. Lack of Assurance of Sterility |
| Oct 14 | Class II | Apothecary Pharma LLC Drug |
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06. Lack of Assurance of Sterility |